Bullous lichen sclerosus atrophicus

Abstract

References1 Hajjeh RA, Conn LA, Stephens DS et al. Cryptococcosis in the United States: population-based multistate active surveillance and risk factors in HIV-infected persons. J Infect Dis 1999; 179 : 449 -454. 2 Gaddoni D, Resta F, Baldassari L et al. Criptococcosi cutanea in corso di AIDS. G Ital Dermatol Venereol 1993; 128 : 129 -132. 3 Vandersmissen G, Meuleman L, Tits G et al. Cutaneous cryptococcosis in corticosteroid-treated patients without AIDS. Acta Clin Belg 1996; 51 (2): 111 -117. 4 Nampoory MR, Khan ZU, Johny KV et al. Invasive fungal infections in renal transplant recipients. J Infect 1996; 33 (2): 95 -101. 5 Krcmery V Jr, Kunova A, Mardiak J. Nosocomial Cryptococcus laurentii fungemia in a bone marrow transplant patient after prophylaxis with ketoconazole successfully treated with oral fluconazole. Infection 1997; 25 (2): 130. 6 Bangert RL, Cho BR, Widders PR et al. A survey of aerobic bacteria and fungi in the feces of healthy psittacine birds. Avian Dis 1988; 32 : 46 -52. 7 Slavikova E, Vadkertiova R. Yeasts and yeast-like organisms isolated from fish-pond waters. Acta Microbiol Pol 1995; 44 (2): 181-189. 8 Bellosta M, Gaviglio MR, Mosconi M et al. Primary cutaneous cryptococcosis in an HIV-negative patient. Eur J Dermatol 1999; 9 (3): 224 -226. 9 Dimino-Emme L, Gurevitch AW. Cutaneous manifestations of disseminated cryptococcosis. J Am Acad Dermatol 1995; 32 (5, Part 2): 844 -850. 10 Kordossis T, Avlami A, Velegraki A et al. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients. Med Mycol 1998; 36 (5): 335 -339. 11 Johnson LB, Bradley SF, Kauffman CA. Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia. References 1 Carlson JA, Murphy M. Androgen receptors and lichen sclerosus (letter). J Am Acad Dermatol 2000; 43: 559. 2 Clifton M, Smoller B. Androgen receptors and lichen sclerosus (reply). J Am Acad Dermatol 2000; 43: 559. 3 Kohlberger PD, Joura EA, Bancher D, Gitsch G, Breitenecker G, Kieback DG. Evidence of androgen receptor expression in lichen sclerosus: an immunohistochemical study. J Soc Gynecol Invest 1998; 5: 331-333. 4 Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet 1999; 353: 1777-1783. 5 Carlson JA, Ambros R, Malfetano J et al. Vulvar lichen sclerosus and squamous cell carcinoma: a cohort, case control, and investigational study with historical perspective; implications for chronic inflammation and sclerosis in the development of neoplasia. J Am Board Fam Pract 1999; 12: 473 -476. 6 Tidy JA, Soutter WP, Luesley DM, MacLean AB, Buckley CH, Ridley CM. Management of lichen sclerosus and intraepithelial neoplasia of the vulva in the UK.

Extragenital Bullous Lichen Sclerosus in a Pediatric Patient: A Case Report and Literature Review

“…Thus, according to the Japanese literature, blister formation is observed more frequently in the extragenital region . This finding has not been clearly established in the English literature . Nonetheless, the occurrence of hemorrhagic bullae in extragenital lichen sclerosus is gaining recognition, and cases such as ours should raise clinical awareness of the probable association between extragenital lichen sclerosus and bullous formation.…”

Acral bullous lichen sclerosus intolerant to UVA‐1 successfully treated with narrowband ultraviolet B phototherapy

“…Recommendations are primarily based on small uncontrolled studies and case reports. Superpotent topical corticosteroids are the first‐line therapy, although they may be less effective than for genital lesions . Other topical treatments include retinoids and calcineurin inhibitors.…”

“…Reports of acral LS are scant, and only two (of eight previously reported cases) had symptomatic milia/bullae formation. 2,4 It has been described as a painful cutaneous disorder. There are few data on the efficacy of treatments for extragenital lichen sclerosus.…”

“…Superpotent topical corticosteroids are the firstline therapy, although they may be less effective than for genital lesions. 1,3,4 Other topical treatments include retinoids and calcineurin inhibitors. Systemic immunosuppressive therapies such as methotrexate have been used with variable outcomes.…”

Lichen sclerosus mimicking Bowen’s disease

“…In many cases there is a close relationship between localized scleroderma and LS. Some authors suggest there are different manifestations of the same disease [14,15].…”